Coya Therapeutics
COYA
56 hedge funds and large institutions have $32M invested in Coya Therapeutics in 2026 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 12 closing their positions.
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
3.38% less ownership
Funds ownership: 37.94% → 34.56% (-3.4%)
3% less funds holding
Funds holding: 58 → 56 (-2)
30% less capital invested
Capital invested by funds: $46M → $32M (-$14M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Prosight Management
Dallas,
Texas
|
+$1.97M |
| 2 |
DCM
DME Capital Management
New York
|
+$1.45M |
| 3 |
PMG
Private Management Group
Irvine,
California
|
+$415K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$302K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$229K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$4.21M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$400K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$231K |
| 4 |
Walleye Capital
New York
|
-$215K |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$200K |
COYA Hedge Fund Activity: Q1 2026 in Review
56 of the 8,131 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q1 2026, worth a combined $32M — down 30% from $46M a quarter earlier.
Fund positioning in COYA was balanced in Q1 2026: 12 funds opened new positions, 12 closed out, 20 added to existing stakes and 11 trimmed.
The largest buyer was Prosight Management, opening a new position worth an estimated $1.97M. The largest seller was AWM Investment Company, exiting entirely with an estimated $4.21M sold.
- 56 institutional investors held Coya Therapeutics (COYA) as of Q1 2026, down from 58 in Q4 2025.
- Funds reported $32M of Coya Therapeutics stock for Q1 2026, down 30% quarter-over-quarter.
- 12 funds opened new Coya Therapeutics positions in Q1 2026 and 12 closed out, a net change of 0 holders.
- The largest Coya Therapeutics buyer in Q1 2026 was Prosight Management, an estimated $1.97M added.
- The largest Coya Therapeutics seller in Q1 2026 was AWM Investment Company, an estimated $4.21M sold.
Based on aggregated 13F filings for Q1 2026.